NUTRITION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2024-06-17 ms9000000357155338 来自山东省

需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2023-04-13 ms8000000584176615 来自浙江省

submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？

74 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2024-04-20 ms3000000138856379 来自浙江省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：医学;食品营养;meta
经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2023-03-18 ms6000000049060211 来自山东省

有点点慢哦，with editor已经一周了还没到下一步

103 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2023-02-14 ms9000001684545834 来自内蒙古

审稿速度:12.0 | 投稿命中率:50.0
经验分享：7月9日上传稿件
7月14日Elsevier推荐了润色网站,没用
10月23审稿意见返回
11月4日返回审稿意见
次年2月18日录用
5月18日online
审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了

77 0

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2022-10-04 ms2000000734303055

审稿速度:6.0 | 投稿命中率:50.0
经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。
总体是6月13日投，10月1号接收，不Open就不收费。

86 0

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2022-06-28 zyl1997

审稿速度:3.0
经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见

78 0

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2022-01-15 医路前行7575

2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论

114 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2022-05-31 ms8000000446291833

审稿速度:2.0 | 投稿命中率:25.0
经验分享：投过去润色结束后拒稿，离大谱

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗？几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了，请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学;食品营养;meta 经验分享：2月14日上传，4月3日给返修意见，4月16日上传修改稿，目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦，with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：7月9日上传稿件 7月14日Elsevier推荐了润色网站,没用 10月23审稿意见返回 11月4日返回审稿意见 次年2月18日录用 5月18日online 审稿专家认真负责，投稿页面清晰明了，没得说，就是太太太慢了，后来又投了Elsevier旗下的期刊依旧很慢，大概六个月左右，虽然Elsevier的期刊口碑不错，但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：文章第一次投稿就选择这个期刊，投过去差不多两天就送审。两个月后返修，让一个月内返修好投过去。两个外审专家，提的意见很专业，发现了文章中很多的错误，耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。 总体是6月13日投，10月1号接收，不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0 经验分享：一审3个月悲剧，只有一个审稿意见，只说了没有创新，没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿，1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗？讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投过去润色结束后拒稿，离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命，珍惜时间，远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]

2022-04-15 Cc66889

珍爱生命，珍惜时间，远离nutrition

134 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务